Skip to Main Content

Author Details

Molly Kulesz-Martin
Oregon Health & Science University
1980
103
32
PMIDPaper TitleJournal TitlePublished Year
35343367Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib.Cancer Biol Ther2022
33096083Inverse Correlation of TRIM32 and Protein Kinase C ζ in T Helper Type 2-Biased Inflammation.J Invest Dermatol2021
31348921Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting.J Invest Dermatol2020
32843430Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma.Cold Spring Harb Mol Case Stud2020
31123703Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains.Sci Adv2019
31214023Natural Product Target Network Reveals Potential for Cancer Combination Therapies.Front Pharmacol2019
31596908Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma.PLoS One2019
29550416Montagna Symposium 2017-Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment.J Invest Dermatol2018
29856687Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models.Cancer Biol Ther2018
30300579Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy.Cancer Cell2018
27720760Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis.J Invest Dermatol2017
28380359Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.Cell Rep2017
28964549Evidence-Based Precision Oncology with the Cancer Targetome.Trends Pharmacol Sci2017
28647024Montagna Symposium 2016-The Skin: Our Sensory Organ for Itch, Pain, Touch, and Pleasure.J Invest Dermatol2017
26876212Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling.Oncogene2016
27107373Montagna Symposium 2015: Harnessing Stem Cells to Reveal Novel Skin Biology and Disease Treatments.J Invest Dermatol2016
25785950Montagna Symposium 2014-skin aging: molecular mechanisms and tissue consequences.J Invest Dermatol2015
25839700Hybrid Capture 2 is as effective as PCR testing for high-risk human papillomavirus in head and neck cancers.Appl Immunohistochem Mol Morphol2015
25938491Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.PLoS One2015
24909985B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.Cancer Cell2014
25029318Montagna symposium 2013-light and skin: how light sustains, damages, treats, images and modifies skin biology.J Invest Dermatol2014
23192268A molecular case report: functional assay of tyrosine kinase inhibitors in cells from a patient's primary renal cell carcinoma.Cancer Biol Ther2013
23594531Montagna Symposium 2012: Keeping it all together--adhesion, the cytoskeleton, and signaling in morphogenesis and tissue function.J Invest Dermatol2013
22133638Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.Oral Oncol2012
22499034Montagna Symposium 2011: 60th Anniversary--Advances in Science and Medicine Catalyzed by Pioneering Skin Research.J Invest Dermatol2012
22649547NF-κB repression by PIAS3 mediated RelA SUMOylation.PLoS One2012
21529065Dermal reflectivity determined by optical coherence tomography is an indicator of epidermal hyperplasia and dermal edema within inflamed skin.J Biomed Opt2011
21997415Montagna Symposium 2010: small molecules: skin as the first line of defense.J Invest Dermatol2011
21822536Tobacco-specific carcinogen nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces AKT activation in head and neck epithelia.Int J Oncol2011
20054338Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes.J Invest Dermatol2010
20393473Montagna Symposium 2009: Genetic-epigenetic Basis of Skin Diseases.J Invest Dermatol2010
19148212Montagna symposium 2008: the biologic basis of psoriasis.J Invest Dermatol2009
18026135p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.Oncogene2008
19055840Global rank-invariant set normalization (GRSN) to reduce systematic distortions in microarray data.BMC Bioinformatics2008
1847800956th annual Montagna Symposium on the Biology of Skin: Epidermal T-cell interactions--clinicopathological and basic mechanisms.J Invest Dermatol2008
18618014Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression.J Clin Invest2008
17460734Noninvasive imaging of melanoma with reflectance mode confocal scanning laser microscopy in a murine model.J Invest Dermatol2007
18006813Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4.Cancer Res2007
17626251Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival.Mol Carcinog2007
17699776p73 loss triggers conversion to squamous cell carcinoma reversible upon reconstitution with TAp73alpha.Cancer Res2007
17435780Signaling to structures: skin appendages, development and diseases--meeting report of the 55th annual Montagna Symposium on the Biology of Skin.J Invest Dermatol2007
16557271Sliding into home: facilitated p53 search for targets by the basic DNA binding domain.Cell Death Differ2006
19529368Imaging the mechanical stiffness of skin lesions by in vivo acousto-optical elastography.Opt Express2006
17069022Highlights of clinician/scientist translational discussion session.J Investig Dermatol Symp Proc2006
16816390The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.J Biol Chem2006
15937546Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.J Clin Invest2005
16297181P53 family activities in development and cancer: relationship to melanocyte and keratinocyte carcinogenesis.J Invest Dermatol2005
16363066Imaging melanoma in a murine model using reflectance-mode confocal scanning laser microscopy and polarized light imaging.J Investig Dermatol Symp Proc2005
16363065Melanocyte and keratinocyte carcinogenesis: p53 family protein activities and intersecting mRNA expression profiles.J Investig Dermatol Symp Proc2005
16363062Current view of the role of transforming growth factor beta 1 in skin carcinogenesis.J Investig Dermatol Symp Proc2005
  • 1 - 50 of 103

Recommended Authors

Northwell Health Cancer Institute
Career Start Year 2006
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 5
Uppsala University
Career Start Year 1991
Number of shared co-authors 0
University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1987
Number of shared co-authors 0
University of Iowa
Career Start Year 1986
Number of shared co-authors 1
University of California
Career Start Year 1984
Number of shared co-authors 2
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 0
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 4
Ludwig Institute for Cancer Research, University of Oxford
Career Start Year 1983
Number of shared co-authors 1
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 1
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 2
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 1
Garvan Institute of Medical Research
Career Start Year 1980
Number of shared co-authors 0
University of Alabama
Career Start Year 1979
Number of shared co-authors 0
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Norwich Medical School, University of East Anglia
Career Start Year 1978
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 0
Battelle Memorial Institute
Career Start Year 1978
Number of shared co-authors 1
Moores Cancer Center, university of california san diego
Career Start Year 1977
Number of shared co-authors 3
The Rockefeller University
Career Start Year 1976
Number of shared co-authors 2
Kresge Hearing Research Institute, University of Michigan ann arbor
Career Start Year 1976
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 2
Baylor College of Medicine
Career Start Year 1975
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Career Start Year 1972
Number of shared co-authors 4
Simons Center for Systems Biology, Institute for Advanced Study
Career Start Year 1967
Number of shared co-authors 0
Oncology R&D
Career Start Year 1966
Number of shared co-authors 2
National Cancer Institute
Career Start Year 1945
Number of shared co-authors 1

Collaborators

Oregon Health & Science University, University of California Berkeley
Co-authored papers 6
Oregon Health & Science University School of Medicine
Co-authored papers 5
Knight Cancer Institute, Oregon Health Sciences University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Regeneron Pharmaceuticals
Co-authored papers 4
Oregon Health & Science University
Co-authored papers 4
Oregon Health & Science University
Co-authored papers 4
Cornell University
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2
St Jude Children's Research Hospital.
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Stanford Cardiovascular Institute, Stanford University
Co-authored papers 2
University of California at Davis
Co-authored papers 2
Icahn School of Medicine
Co-authored papers 2
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
HudsonAlpha Institute for Biotechnology, Stanford University
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
University of Washington
Co-authored papers 1
University of Michigan ann arbor
Co-authored papers 1